---
layout: minimal-medicine
title: Doxorubicin
---

# Doxorubicin
### Generic Name
Doxorubicin

### Usage

Doxorubicin is a potent chemotherapy drug belonging to the anthracycline family.  Its primary use is in the treatment of various cancers, either as a single agent or in combination with other chemotherapeutic drugs.  It's effective against a wide range of solid tumors and hematological malignancies.  Specific cancers treated include:

* **Breast cancer:** Doxorubicin is a cornerstone of many breast cancer treatment regimens, often used in combination with other drugs like cyclophosphamide (in AC, ddAC, CAF, FAC, and TAC regimens) before or after surgery.

* **Acute lymphoblastic leukemia (ALL):** Doxorubicin plays a role in several ALL treatment protocols, usually in combination with other agents (Hyper-CVAD, CALGB 8811).

* **Bladder cancer:**  It's used in combination regimens (MVAC) for both locally advanced and metastatic disease, and sometimes neoadjuvantly (before surgery).

* **Ewing's sarcoma:** Doxorubicin features in several combination therapies for Ewing's sarcoma (VAC/IE, VAIA, VIDE).

* **Hodgkin lymphoma:** Various combination chemotherapy regimens for Hodgkin lymphoma incorporate doxorubicin (ABVD, A-AVD, BEACOPP, Stanford V).

* **Non-Hodgkin lymphoma:**  Doxorubicin is used in combination with other drugs (CHOP, RCHOP, Hyper-CVAD + Rituximab, dose-adjusted EPOCH or REPOCH, Nordic, RCHOP/RDHAP, R-CODOX-M/IVAC) to treat different types of Non-Hodgkin lymphoma.

* **Osteosarcoma:** Doxorubicin is part of several multi-drug protocols for osteosarcoma, both pre- and post-operatively (cisplatin/doxorubicin, high-dose methotrexate/cisplatin/doxorubicin/ifosfamide, MAP).

* **Small-cell lung cancer:**  It is used in combination with other chemotherapy agents (CAV) for recurrent disease.

* **Soft tissue sarcoma:** Doxorubicin is employed in various combination regimens for soft tissue sarcomas (AD, AIM, MAID).

* **Rhabdomyosarcoma:** Doxorubicin is part of combination chemotherapy for rhabdomyosarcoma (VAC/IE, VAI).

**Off-label uses:** Doxorubicin is also sometimes used off-label (meaning not officially approved for this use) to treat other cancers like endometrial carcinoma, multiple myeloma, thymomas, uterine sarcoma, Waldenstrom macroglobulinemia, hepatocellular carcinoma, renal carcinoma, salivary gland cancers.  These uses should only be considered under the close supervision of an oncologist.


### Dosage

Doxorubicin dosage is highly individualized and depends on the specific cancer being treated, the patient's overall health, other medications being taken, and the treatment regimen being used.  Dosage is usually calculated based on the patient's body surface area (mg/mÂ²) or weight (mg/kg).  It's administered intravenously (IV), and the specific schedule (e.g., frequency, duration) varies greatly depending on the treatment protocol.  

**Detailed dosage information is complex and highly variable, and should only be determined by a qualified oncologist familiar with the specific cancer and patient situation.  The information provided in the source material is extensive and includes numerous regimens for various cancers.  Attempting to summarize this here would be inaccurate and potentially dangerous.**

Always refer to the prescribing information provided by your physician or pharmacist for accurate and complete dosage instructions.  Self-medicating with doxorubicin is extremely dangerous and should never be attempted.


### Side Effects

Doxorubicin can cause a wide range of side effects, some common and others less frequent but potentially serious.  These include:

* **Common (affecting >10% of patients):** Anemia, alopecia (hair loss), anorexia (loss of appetite), congestive heart failure (CHF), constipation, diarrhea, fatigue, leukopenia (low white blood cell count), nausea, neutropenia (low neutrophil count), pruritus (itching), rash, stomatitis (mouth sores), thrombocytopenia (low platelet count), vomiting.

* **Less common but serious:** Cardiomyopathy (heart muscle damage),  acute and delayed cardiotoxicity,  tumor lysis syndrome,  hyperuricemia,  extravasation (leakage from the vein during injection), secondary malignancies (e.g., leukemia),  severe myelosuppression (bone marrow suppression),  infertility, GI ulceration, and others.

**Any new or worsening symptoms should be reported to a healthcare professional immediately.**


### How it Works

Doxorubicin's primary mechanism of action is the inhibition of topoisomerase II, an enzyme crucial for DNA replication and repair.  By inhibiting this enzyme, doxorubicin prevents DNA from unwinding and replicating properly, leading to DNA damage and ultimately cell death in rapidly dividing cancer cells.  Additionally, it intercalates (inserts itself) between DNA base pairs, further disrupting DNA function and contributing to its cytotoxic effects.  The drug also acts as an iron chelator, forming complexes that can generate free radicals which also damage cellular components.


### Precautions

* **Cardiotoxicity:** Doxorubicin is known to cause potentially life-threatening cardiotoxicity (damage to the heart muscle).  Regular monitoring of heart function (e.g., echocardiograms) is crucial during and after treatment.

* **Myelosuppression:**  The drug significantly suppresses bone marrow function, leading to decreased blood cell counts (anemia, leukopenia, thrombocytopenia). This increases the risk of infections and bleeding.  Regular blood tests are essential to monitor this.

* **Extravasation:** If doxorubicin leaks out of the vein during administration (extravasation), it can cause severe tissue damage. Careful administration and immediate intervention if extravasation occurs are necessary.

* **Other precautions:** Doxorubicin may interact with other medications, affecting their efficacy or increasing toxicity.  It's crucial to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and herbal supplements.  It should be avoided in patients with severe hepatic impairment, severe cardiac disease, and hypersensitivity to anthracyclines.  Pregnancy and breastfeeding are contraindications.


### FAQs

* **Q: How is doxorubicin stored?** A: Doxorubicin should be stored as directed by your physician or pharmacist, usually refrigerated and protected from light.

* **Q: How long does it take to work?** A: The effects of doxorubicin are not immediate.  It takes time for the drug to work and for the tumor to respond.  Regular monitoring by oncologists is essential to assess treatment effectiveness.

* **Q: What should I do if I miss a dose?** A: Never attempt to adjust the dosage or schedule yourself. Contact your doctor immediately for guidance.

* **Q:  Can I drink alcohol while on doxorubicin?** A:  Alcohol consumption should be avoided while receiving doxorubicin treatment, as it can exacerbate side effects, particularly liver toxicity.

* **Q: Are there long-term effects?** A: Yes, long-term side effects are possible, including cardiac dysfunction, secondary malignancies, and infertility.  Regular follow-up appointments are important for long-term monitoring and management.

**Disclaimer:** This information is for general knowledge and does not constitute medical advice.  Always consult with a qualified healthcare professional before starting any medication, particularly a chemotherapy drug like doxorubicin.  The information provided here is a summary and does not replace the complete prescribing information that should be consulted by healthcare providers.
